XIN HU
Assistant Professor
Adjunct Assistant Professor
Adjunct or Visiting, Health Policy and Management
Xin Hu, PhD, MSPH, is an Assistant Professor in the Division of Health Services Research, Outcomes, and Policy of the Department of Radiation Oncology at Emory University School of Medicine. She is a Visiting Scientist at the American Cancer Society. She received her PhD and master degree in Health Services Research and Health Policy at Emory University, and her bachelor degree in Public Service Administration from Fudan University. Prior to her PhD degree, she worked at the Yale Cancer Outcomes, Public Policy and Effectiveness Research Center and the Yale Center for Analytical Sciences.
Dr. Hu's research focuses on cancer outcomes, health care quality and health disparities, and she specializes in leveraging causal inference methods with administrative health records, national survey data, and other secondary data sources to evaluate national health policies and conduct population-based health services research. Her current research interests include:
1) The role of provider characteristics and organizational structures of oncology market on cancer care delivery and outcomes
2) Health policy evaluation in the cancer population, including Medicaid expansion, Medicare payment, and opioid prescription policies
3) Racial disparities in cancer care delivery and outcomes
Dr. Hu's research has been published in JAMA Oncology, JAMA Network Open, Journal of National Cancer Institute, and Medical Care. She serves on the editorial board of Health Services Research and has been a journal reviewer for Journal of Clinical Oncology, Journal of National Cancer Institute, JAMA Network Open, Journal of the National Comprehensive Cancer Network, Medical Care, Health Services Research and eClinicalMedicine.
Areas of Interest
- Cancer Prevention
- Health Disparities
- Health Economics
- Health Outcomes
- Health Policy
- Health Services Research
Education
- Bachelor of Management 2013, Fudan University
- Master of Science in Public Health 2015, Emory University
- PhD 2023, Emory University
Affiliations & Activities
Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine (Primary Appointment)
Adjunct Faculty, Department of Health Policy and Management, Emory University Rollins School of Public Health
Adjunct Faculty, Department of Pediatrics, Emory University School of Medicine
Publications
- Hu X; McCarthy I; Yabroff KR; You W; Lipscomb J; Graetz I, 2024, Association Between Medicare Site-Based Payment Policy, Physician Practice Characteristics, and Vertical Integration Among Oncologists., JCO Oncology Practice, ,
- Hu X; Grosse SD; Han X; Marchak JG; Ji X, 2024, Mental Health Care Utilization Among Parents of Children With Cancer., JAMA Open, ,
- Hu X; Jiang C; Fan Q; Shi KS; Parikh RB; Kamal AH; Anderson RT; Yabroff KR; Han X, 2024, US Medicare Hospice and Palliative Medicine Physician Workforce and Service Delivery in 2008-2020., J Pain Symptom Manage, ,
- Hu X, Brock KE, Effinger KE, Zhang B, Graetz I, Lipscomb J, Ji X, 2022, Changes in Opioid Prescriptions and Potential Misuse and Substance Use Disorders Among Childhood Cancer Survivors Following the 2016 Opioid Prescribing Guideline., JAMA Oncology, 9,
- Hu X, Kaplan C, Martin MY, Walker MS, Stepanski E, Schwartzberg L, Vidal G, Graetz I, 2022, Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor positive breast cancer., Cancer Epidemiol Biomarkers Prev, 9,
- Hu X, Walker MS, Stepanski E, Kaplan CM, Martin MY, Vidal GA, Schwartzberg LS, Graetz I., 2022, Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer. , JAMA Network Open, ,
- Hu X, Lipscomb J, Jiang C, Graetz I., 2022, Vertical integration of oncologists and cancer outcomes and costs in metastatic Castration-Resistant prostate cancer., J Natl Cancer Inst, 0,
- Hu X, Chehal PK, Kaplan C, Krukowski RA, Lan RH, Stepanski E, Schwartzberg L, Vidal G, Graetz I, 2021, Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy, JAMA Network Open, 4, e2112076
- Han X, Hu X, Zhao J, Ma J, Jemal A, Yabroff KR., 2021, Trends of Cancer-Related Suicide in the United States: 1999-2018, J Natl Cancer Inst, 113, 1258-1262
- Phillips VL, Hu X. , 2020, Association of healthy child-rearing practices and children's receipt of care in patient-centered medical homes, Journal of Child Health Care, 25, 290-304
- Graetz I, Yarbrough CR, Hu X, Howard DH, 2020, Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist., JAMA Oncology, 6, 1102-1103
- Zeidan AM, Hu X, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Bewersdorf JP, Podoltsev NA, Gore SD, Ma X, Davidoff AJ., 2020, Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents. , Leukemia Lymphoma, 61, 397-408
- Davidoff AJ*, Hu X*, Bewersdorf JP, Wang R, Podoltsev NA, Huntington SF, Gore SD, Ma X, Zeidan AM. , 2020, Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study., Leukemia Lymphoma, 61, 1178-1187
- Diaz MM, Hu X, Fenton BT, Kimuli I, Lee A, Lindsey H, Bigelow JK, Maiser S, Altalib HH, Sico JJ, 2020, Prevalence of and characteristics associated with in-hospital mortality in a Ugandan neurology ward. , BMC Neurology, 20, 1-13
- Smith TG, Strollo S, Hu X, Earle CC, Leach CR, Nekhlyudov L, 2019, Understanding Long-Term Cancer Survivors' Preferences for Ongoing Medical Care. , Journal of General Internal Medicine, 34, 2091-2097
- Davidoff AJ, Guy GP Jr, Hu X, Gonzales F, Han X, Zheng Z, Parsons H, Ekwueme DU, Jemal A., 2018, Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History: Population-based National Estimates., Medical Care, 56, 220
- Zeidan AM, Stahl M, Hu X, Wang R, Huntington SF, Podoltsev NA, Gore SD, Ma X, Davidoff AJ, 2018, Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation. , Blood, 131, 818
- Hu X, Phillips VL, Gaydos LM, Joski P. , 2017, Association of Healthy Home Environments and Use of Patient-Centered Medical Homes by Children of Low-Income Families. , Journal of Pediatric Health Care, 31, 203-214
- Stratton J, Hu X, Soulos PR, Davidoff AJ, Pusztai L, Gross CP, Mougalian SS., 2017, Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors., Journal of Oncology Practice, 13, e505-e515
- Zeidan AM, Hu X, Long JB, Wang R, Ma X, Podoltsev NA, Huntington SF, Gore SD, Davidoff AJ. , 2017, Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study. , Cancer, 123, 3754-3762
- Zeidan AM, Davidoff AJ, Long JB, Hu X, Wang R, Ma X, Gross CP, Abel GA, Huntington SF, Podoltsev NA, Hajime U, Prebet T, Gore SD. , 2016, Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. , British Journal of Haematology, 175, 829-840